These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6765151)

  • 41. Role of islet cell antibodies in the pathogenesis of type I diabetes.
    Brogren CH; Baekkeskov S; Dyrberg T; Lernmark A; Marner B; Nerup J; Papadopoulos GK
    Curr Probl Clin Biochem; 1983; 12():65-85. PubMed ID: 6360543
    [No Abstract]   [Full Text] [Related]  

  • 42. Detection of islet cell surface antibodies using cloned beta cells and comparison of their incidence with that of islet cell cytoplasmic antibodies.
    Grant AM; Harrison DE; Moysey L; Smith D; Ashcroft SJ
    Diabetes Res; 1985 Sep; 2(5):225-9. PubMed ID: 3905186
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antioxidant enzyme activity and mRNA expression in the islets of Langerhans from the BB/S rat model of type 1 diabetes and an insulin-producing cell line.
    Sigfrid LA; Cunningham JM; Beeharry N; Håkan Borg LA; Rosales Hernandez AL; Carlsson C; Bone AJ; Green IC
    J Mol Med (Berl); 2004 May; 82(5):325-35. PubMed ID: 15007513
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Early appearance of complement-dependent antibody mediated cytotoxicity (C'AMC) to islet cells in serum of diabetes-prone BB/OK rats.
    Hehmke B; Schröder D; Klöting I
    Diabetes Res; 1990 Apr; 13(4):183-6. PubMed ID: 2134210
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Human islet cell autoantibodies specifically bind cloned rat islet cells.
    Thivolet CH; Durand A; Chatelain P; Bertrand J
    Diabetes Res; 1987 Oct; 6(2):71-6. PubMed ID: 3322634
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Correlations between the presence of islet cell surface antibodies in human serum and the cytotoxic effects on rat islet beta-cells.
    Jahr H; Marx S; Besch W; Ratzmann KP
    Acta Biol Med Ger; 1982; 41(12):1099-1103. PubMed ID: 6765150
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Different islet protein expression profiles during spontaneous diabetes development vs. allograft rejection in BB-DP rats.
    Christensen UB; Larsen PM; Fey S; Karlsen AE; Pociot F; Nerup J; Sparre T
    Autoimmunity; 2006 Jun; 39(4):315-21. PubMed ID: 16891220
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cytotoxicity towards neonatal versus adult BB rat pancreatic islet cells.
    Ekblond A; Schou M; Buschard K
    Autoimmunity; 1995; 20(2):93-8. PubMed ID: 7578873
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cell surface antibodies in type 1 (insulin-dependent) diabetic patients. I. Presence of immunoglobulins M which bind to rat pituitary cells.
    Vercammen M; Gorus F; Foriers A; Segers O; Somers G; Van de Winkel M; Pipeleers D
    Diabetologia; 1989 Aug; 32(8):611-7. PubMed ID: 2673894
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Insulin autoantibodies, islet cell surface antibodies and the development of spontaneous diabetes in the BB/Edinburgh rat.
    Dean BM; Bone AJ; Varey AM; Walker R; Baird JD; Cooke A
    Clin Exp Immunol; 1987 Aug; 69(2):308-13. PubMed ID: 3308226
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cell surface antigens on rat islet tumors.
    Thomas JW; Virta VJ; Nell LJ
    J Immunol; 1987 May; 138(9):2896-901. PubMed ID: 3033078
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Detection of islet cell autoantibodies in newly diagnosed diabetic patients using insulin-producing Syrian hamster cells.
    Matsuba I; Marner B; Nerup J; Lernmark A
    Diabetes Res; 1987 Mar; 4(3):103-7. PubMed ID: 3301157
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Splenocytes from non-obese-diabetic mice binding to xenogeneic beta-cells in vitro: an early marker of cell-mediated immunity.
    Martignat L; Feve B; Charbonnel B; Sai P
    Diabete Metab; 1993; 19(6):566-74. PubMed ID: 8026608
    [TBL] [Abstract][Full Text] [Related]  

  • 54. T-splenocytes from non-obese diabetic mice binding to xenogeneic pancreatic beta-cells in vitro. Implication of the alpha/beta T-cell receptor and of major histocompatibility complex class II molecules from target cells.
    Martignat L; Feve B; Ouary M; Pogu S; Charbonnel B; Saï P
    J Autoimmun; 1993 Dec; 6(6):753-69. PubMed ID: 8155255
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antibodies to a Mr-64,000 islet cell protein in Swedish children with newly diagnosed type 1 (insulin-dependent) diabetes.
    Christie M; Landin-Olsson M; Sundkvist G; Dahlquist G; Lernmark A; Baekkeskov S
    Diabetologia; 1988 Aug; 31(8):597-602. PubMed ID: 3065114
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Apoptosis and disease progression in the spontaneously diabetic BB/S rat.
    Lally FJ; Ratcliff H; Bone AJ
    Diabetologia; 2001 Mar; 44(3):320-4. PubMed ID: 11317663
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Islet-cell-surface antibodies in juvenile diabetes mellitus.
    Lernmark A; Freedman ZR; Hofmann C; Rubenstein AH; Steiner DF; Jackson RL; Winter RJ; Traisman HS
    N Engl J Med; 1978 Aug; 299(8):375-80. PubMed ID: 353557
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vitro natural killer cell activity in the spontaneously diabetic BB/Wor rat: effects of serum on lysis of insulinoma cells.
    Koevary SB
    Diabetes Res; 1988 Jun; 8(2):77-84. PubMed ID: 2852569
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Influence of target cell preparation on binding of monoclonal islet cell reactive antibodies (mc-ICRA) in cellular enzyme-linked immunosorbent assay (CELISA).
    Schlosser M; Witt S; Ziegler B; Ziegler M
    J Immunol Methods; 1991 Jun; 140(1):101-9. PubMed ID: 2061606
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Detection of antibodies against pancreatic islet cells in clinical practice].
    Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L
    Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.